MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

5 Dividend Growth Stocks With Upside To Analyst Targets
Thursday, April 5, 8:49 AM ET, by Market News Video Staff

To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently ...

May 25th Options Now Available For The Materials Select Sector SPDR Fund (XLV)
Thursday, April 5, 11:28 AM ET, by Market News Video Staff

Investors in The Materials Select Sector SPDR Fund (XLV) saw new options begin trading today, ...

Friday Sector Laggards: Healthcare, Industrial
Friday, April 6, 2:38 PM ET, by Market News Video Staff

The worst performing sector as of midday Friday is the Healthcare sector, showing a 2.9% ...

PFE Named 'Top Dividend Stock of the Dow' at Dividend Channel With 3.9% Yield
Monday, April 9, 7:28 AM ET, by Market News Video Staff

Pfizer Inc (PFE) has been named as the ''Top Dividend Stock of the Dow'', according ...

We Did The Math USMV Can Go To $58
Monday, April 9, 9:06 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

ETFs Impacted by Merck Results on Friday Morning

By Market News Video Staff, Friday, October 29, 9:22 AM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

This morning, Merck (NYSE:MRK) announced third quarter earnings of 85 cents per share, ex-items, narrowly beating Wall Street estimates of 82 cents per share. Though, with the stock trading lower in the pre-market, it appears traders are more focused on the top line miss by the company. Revenue for the third quarter came in at $11.12 billion, just short of the consensus estimate of $11.24 billion.

Merck's news is sure to impact a number of ETFs heavily weighted towards the pharmaceutical giant. The Pharmaceutical HOLDRS ETF (NASDAQ:PPH) holds 18.47% of its portfolio in Merck, second only to Johnson & Johnson (NYSE:JNJ) and the Health Care Select Sector SPDR Fund (AMEX:XLV) holds 9.37% of its portfolio in Merck, the third largest holding behind Johnson & Johnson and Pfizer (NYSE:PFE). For a full list of ETFs holding shares of Merck, visit the ETFs Containing MRK page.


ETF CHANNEL WILL BE LAUNCHING THE "ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO"

Register Today to be alerted when we launch, and we'll offer you a 20% discount on your first year of service! The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.


This Article's Word Cloud:   AMEX   Care   Channel   Containing   ETFs   Flexible   Fund   Growth   Health   Investment   Johnson   Merck   NYSE   Pfizer   Pharmaceutical   Portfolio   Register   Revenue   SPDR   Sector   Select   Street   This   Though   Today   WILL   Wall   alerted   allocation   allows   announced   anywhere   appears   asset   beating   behind   billion   bonds   came   cash   cents   classes   designed   holding   holds   portfolio   quarter   share   short   third
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

ETFs Impacted by Merck Results on Friday Morning | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.